Navigation Links
Cornerstone BioPharma Announces Completion of Merger with Critical Therapeutics
Date:11/3/2008

cts; our ability to transition our management teams effectively; patient, physician and third-party payor acceptance of our products as safe and effective therapeutic products; our heavy dependence on the commercial success of a small number of currently marketed products; our ability to maintain regulatory approvals to market and sell our products; our ability to enter into additional strategic licensing, collaboration or co-promotion transactions on favorable terms, if at all; our ability to maintain compliance with NASDAQ listing requirements; adverse side effects experienced by patients taking our products; difficulties relating to clinical trials, including difficulties or delays in the completion of patient enrollment, data collection or data analysis; the results of preclinical studies and clinical trials with respect to our products under development and whether such results will be indicative of results obtained in later clinical trials; our ability to obtain, maintain and enforce patent and other intellectual property protection for our products and product candidates; and the other factors described in Critical Therapeutics' Quarterly Report on Form 10-Q for the quarter ended September 30, 2008, as amended, filed with the SEC and other SEC filings, including, but not limited to, those set forth in the section entitled "Risks Related to Cornerstone" beginning on page 59 of the proxy statement/prospectus Critical Therapeutics filed with the SEC pursuant to Rule 424(b)(3) on October 6, 2008, and in other filings that Cornerstone Therapeutics makes with the SEC. If one or more of these factors materialize, or if any underlying assumptions prove incorrect, our actual results, performance or achievements may vary materially from any future results, performance or achievements expressed or implied by these forward-looking statements.

In addition, the statements in this press release reflect our expectations and beliefs as of the date of this release. We a
'/>"/>

SOURCE Cornerstone BioPharma Holdings, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Carnegie Mellons Tepper School of Business to Host 2008 Cornerstones Symposium on Building City of the Future, March 25
2. Cornerstone Therapeutics, Inc. Taps Josh Franklin to Head Marketing Team
3. PDL BioPharma to Actively Seek Sale of Entire Company or Its Key Assets
4. Presentation Time Correction: Keryx Biopharmaceuticals Presents at 12:00pm, ET Tomorrow (Oct. 3) at William Blair & Company Small-Cap Growth Stock Conference
5. Nabi Biopharmaceuticals Announces Third Quarter 2007 Financial Results and Positive Vote from November 8, 2007 Special Stockholders Meeting
6. Nabi Biopharmaceuticals Completes Sale of Nabi Biologics to Biotest AG
7. Keryx Biopharmaceuticals, Inc. Announces Poster Presentations Highlighting Observed Clinical Activity of KRX-0401 (Perifosine) to be Presented at the Upcoming American Society of Hematology Meeting in Atlanta, Georgia
8. Aladdin eToken First Strong Authentication Device to Achieve Certification from the SAFE-BioPharma Association
9. XTL Biopharmaceuticals Announces Financial Results for the Year Ended December 31, 2007
10. ARCA Discovery Changes Name to ARCA biopharma to Reflect Focus on Drug Commercialization
11. CeNeRx BioPharma Appoints Mahnaz Asgharnejad as Vice President of Clinical Development
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/30/2015)... May 30, 2015 You've probably heard that ... and hearing loss. However, have you found a better way ... Olathe, Kan., have exactly what you need. , They developed ... build-up; dirt and dead, dry skin from the ears. What's ... swabs or anything on the market today for children and ...
(Date:5/30/2015)... The results of a 40+ year study in ... to cause mesothelioma, regardless of the volume of exposure. ... Surviving Mesothelioma website. , The study conducted by ... found that, among the 138 cases of mesothelioma that ... of them happened at plants that had, at some ...
(Date:5/30/2015)... 30, 2015 ProIntro Magnify contains 30 self-animating ... animations. Instantly add an elegant opening title to any ... range of clean design layouts. ProIntro Magnify is created exclusively ... extremely easy to use. Simply drag a preset into the ... and parameters in the Inspector window then watch as ProIntro ...
(Date:5/30/2015)... At 73 years old, Lynn Kendall ... which she attributes to a lifetime of being health-conscious. She ... the release of her new book titled “ Cook for ... for Health and Longevity” features a collection of recipes and ... food . It is designed to encourage a lifestyle of ...
(Date:5/30/2015)... CA (PRWEB) May 30, 2015 ... today that she is offering a free analysis and ... The offer coincides with Disability Awareness Month, which was ... Industry members across the United States such as Polk ... to raise awareness about the possibility of disability, as ...
Breaking Medicine News(10 mins):Health News:Improved Ear Hygiene Tool Invented by InventHelp Clients (KSC-952) 2Health News:New Study Finds Close Link Between Crocidolite Asbestos and Deadly Mesothelioma, According to Surviving Mesothelioma 2Health News:Announcing the release of ProIntro Magnify from Pixel Film Studios. 2Health News:Lynn Kendall Shows How to ‘Cook for Health and Longevity’ 2Health News:Lynn Kendall Shows How to ‘Cook for Health and Longevity’ 3Health News:San Luis Obispo Insurance Agent Susan Polk Offering Complementary Insurance Analysis In Honor Of Disability Awareness Month 2
... MAKO Surgical Corp., a,developer of minimally invasive, ... that Frederic H. Moll, M.D.,has been named to ... Dr. Moll has over 20 years experience ... Hansen Medical Inc. in September 2002 and,currently serves ...
... Sept. 14 NNN Healthcare/Office REIT,Inc. has acquired ... closed on September 10, 2007. 2750 Monroe ... 106,000 square feet, as well as an accessory ... square feet, on a 10.5-acre parcel,in the Valley ...
... is a,Statement by Oscar S. Wyatt, Jr.: "I,ve seen some press reports about candidates for ... funds received from me, please return them in the form of a,donation to the DeBakey Medical ... ... ...
... AMERIGROUP,Corporation (NYSE: AGP ) will host an Investor ... held at the Grand Hyatt Hotel in New York ... management team,beginning at 8:30 a.m. Eastern Time. The ... of,AMERIGROUP,s National Advisory Board on Improving Healthcare Services for,Seniors ...
... following is a,statement by Mike Leavitt, Secretary of Health ... Rich McKeown, returns to Beijing as the,head of a ... my,Department, to begin formal negotiations on two binding Agreements ... of food and feed, and one on,the safety of ...
... PRGO ; TASE) today announced that President and CEO, ... a review of the Company,business for the financial community ... in New York. The meeting will be made ... or by phone at 866-383-5538, participant,code 10972. Presentations ...
Cached Medicine News:Health News:MAKO Surgical Corp. Names Frederic H. Moll, M.D. to Board of Directors 2Health News:NNN Healthcare/Office REIT Acquires 2750 Monroe Boulevard in Valley Forge, Pennsylvania 2Health News:NNN Healthcare/Office REIT Acquires 2750 Monroe Boulevard in Valley Forge, Pennsylvania 3Health News:AMERIGROUP Corporation to Host Investor Day 2Health News:Perrigo Company to Host Analyst Meeting on September 18, 2007 2
(Date:5/29/2015)... , May 29, 2015 Amgen (NASDAQ: ... two pivotal Phase 3, global, randomized, placebo-controlled trials ... treatment of secondary hyperparathyroidism (SHPT) in patients with ... met the primary endpoint, demonstrating that a greater ... achieved a greater than 30 percent reduction in ...
(Date:5/29/2015)... Pa. , May 29, 2015 ... focus of the Association for the Advancement of ... With support from AAWC,s corporate partners, ... Educational Portal on the AAWC website at ... a wound care pathway with links to various ...
(Date:5/28/2015)... 2015 Zimmer Holdings, Inc. (NYSE and SIX: ... with buyers to divest in the United ... assets, Biomet Discovery® Elbow System assets and Cobalt™ bone ... Zimmer,s pending acquisition of Biomet, Inc. ("Biomet").  ... constructively with the Bureau of Competition Staff of the ...
Breaking Medicine Technology:Amgen Presents Pooled Phase 3 AMG 416 Data For The Treatment Of Secondary Hyperparathyroidism In Patients With Chronic Kidney Disease 2Amgen Presents Pooled Phase 3 AMG 416 Data For The Treatment Of Secondary Hyperparathyroidism In Patients With Chronic Kidney Disease 3Amgen Presents Pooled Phase 3 AMG 416 Data For The Treatment Of Secondary Hyperparathyroidism In Patients With Chronic Kidney Disease 4Amgen Presents Pooled Phase 3 AMG 416 Data For The Treatment Of Secondary Hyperparathyroidism In Patients With Chronic Kidney Disease 5Amgen Presents Pooled Phase 3 AMG 416 Data For The Treatment Of Secondary Hyperparathyroidism In Patients With Chronic Kidney Disease 6Amgen Presents Pooled Phase 3 AMG 416 Data For The Treatment Of Secondary Hyperparathyroidism In Patients With Chronic Kidney Disease 7The Association for the Advancement of Wound Care Educates the Public 2Zimmer Announces Agreements in Furtherance of Pending Biomet Merger 2Zimmer Announces Agreements in Furtherance of Pending Biomet Merger 3Zimmer Announces Agreements in Furtherance of Pending Biomet Merger 4Zimmer Announces Agreements in Furtherance of Pending Biomet Merger 5Zimmer Announces Agreements in Furtherance of Pending Biomet Merger 6
... 2011 Science, public health, and regulatory ... this document is designed for credentialed journalists. Release dates and ... (Logo: http://photos.prnewswire.com/prnh/20090824/FDALOGO ) ... or enforcement actions due to legal limitations. ...
... 26, 2011 Kensey Nash Corporation (Nasdaq: ... Global Healthcare Conference in London on Tuesday, September 27th, ... the Company,s presentation at the Jefferies 2011 Global Healthcare ... approximately at 12:00 p.m. (ET).  To hear the live ...
Cached Medicine Technology:FDA News & Notes - Week of September 26, 2011 2
... of America is the largest, ... lab network in the United ... Crizal coating centers, Essilor offers ... premium quality on the best-selling ...
Bambi database allows images, analytical results, and eyebank or clinical information to be stored in an easy-to-access database. In most cases, the analytical results from any of our analysis progra...
This computerized retail software is aimed for opticians/optometrists, optical chains/1 hr superstores, optical HMOs, and ophthalmology groups....
... SDS Recall marketing software enables the efficient ... The module also has many built-in time ... auto capitalization of name fields and numerous ... and accurate data input. The pre-defined options ...
Medicine Products: